Scholarlink

Erzofri® is a long-acting injectable (LAI) antipsychotic agent that provides a dosage formulation without the need for a second loading dose compared to Invega Sustenna®, which requires two injections. This chapter provides clinical pearls on how to appropriately prescribe and administer Erzofri®.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Paliperidone Palmitate (Erzofri®): Second-Generation Antipsychotic Long-Acting Injectable

  • 章节

  • 发表日期：

    2025年

查看全文
  • Megan J. Ehret

摘要

Erzofri® is a long-acting injectable (LAI) antipsychotic agent that provides a dosage formulation without the need for a second loading dose compared to Invega Sustenna®, which requires two injections. This chapter provides clinical pearls on how to appropriately prescribe and administer Erzofri®.